Article thumbnail

Familial Follicular Cell-Derived Thyroid Carcinoma

By Eun Ju Son and Vânia Nosé

Abstract

Follicular cell-derived well-differentiated thyroid cancer, papillary (PTC) and follicular thyroid carcinomas comprise 95% of all thyroid malignancies. Familial follicular cell-derived well-differentiated thyroid cancers contribute 5% of cases. Such familial follicular cell-derived carcinomas or non-medullary thyroid carcinomas (NMTC) are divided into two clinical–pathological groups. The syndromic-associated group is composed of predominately non-thyroidal tumors and includes Pendred syndrome, Warner syndrome, Carney complex (CNC) type 1, PTEN-hamartoma tumor syndrome (PHTS; Cowden disease), and familial adenomatous polyposis (FAP)/Gardner syndrome. Other conditions with less established links to the development of follicular cell-derived tumors include ataxia–telangiectasia syndrome, McCune Albright syndrome, and Peutz–Jeghers syndrome. The final group encompasses syndromes typified by NMTC, as well as pure familial (f) PTC with or without oxyphilia, fPTC with multinodular goiter, and fPTC with papillary renal cell carcinoma. This heterogeneous group of diseases does not have the established genotype–phenotype correlations known as in the familial C-cell-derived tumors or medullary thyroid carcinomas (MTC). Clinicians should have the knowledge to identify the likelihood of a patient presenting with thyroid cancer having an additional underlying familial syndrome stemming from characteristics by examining morphological findings that would alert pathologists to recommend that patients undergo molecular genetic evaluation. This review discusses the clinical and pathological findings of patients with familial PTC, such as FAP, CNC, Werner syndrome, and Pendred syndrome, and the heterogeneous group of familial PTC

Topics: Endocrinology
Publisher: Frontiers Research Foundation
OAI identifier: oai:pubmedcentral.nih.gov:3356064
Provided by: PubMed Central

Suggested articles

Citations

  1. (2001). A comprehensive analysis of MNG1, TCO1, fPTC, PTEN, TSHR, and TRKA in familial nonmedullary thyroidcancer:confirmationoflinkage to TCO1.
  2. (2006). A new form of familial multi-nodular goitre with progression to differentiated thyroid cancer.
  3. (2004). Abnormal distribution and hyperplasia of thyroid C-cells in PTEN-associated diseases.
  4. (2012). accepted: 13
  5. and Kebebew,E.(2009).Clinicalfeatures and genetic predisposition to hereditary nonmedullary thyroid cancer.
  6. and Klempnauer,J.(2000).Familialpapillary thyroid carcinoma: genetics, criteria for diagnosis, clinical features, and surgical treatment.
  7. Asa,S.,andBapat,B.(1999).Familial adenomatous polyposis-associated thyroid cancer: a clinical, pathological, and molecular genetics study.
  8. (1999). At least three genes account for familial papillary thyroid carcinoma: TCO and MNG1 excluded as susceptibility loci from a large Tasmanian family.
  9. (2007). Cancer Facts and Figures
  10. (1998). Carney complex: diagnosis and management of the complex of spotty skin pigmentation,myxomas,endocrineoveractivity, and schwannomas.
  11. (2003). Chromosome 2 (2p16) abnormalities in Carney complex tumours.
  12. (1999). Cribriform-morular variant of papillary carcinoma: a distinctive variant representing the sporadiccounterpartoffamilialadenomatous polyposis-associated thyroid carcinoma?
  13. (1995). Diagnosis and therapy of hereditary polyposis syndromes.
  14. (1994). Familial adenomatous polyposis associated thyroidcarcinoma:adistincttypeoffollicularcellneoplasm.Histopathology 25,
  15. (2010). Familial follicular cell tumors: classification and morphological characteristics.
  16. (2012). Familial follicular cell-derived thyroid carcinoma.
  17. (2005). Familial nonmedullary thyroid cancer.
  18. (2008). Familial nonmedullary thyroid carcinoma: an update.
  19. (2001). Familial nonmedullarythyroidneoplasia.Endocr.
  20. (1999). Familial papillarythyroidcarcinomaisgenetically distinct from familial adenomatous polyposis coli.
  21. (2005). Familial risks for nonmedullary thyroid cancer.
  22. (2001). Familial thyroid cancer.
  23. (2008). Familial thyroid carcinoma a diagnostic algorithm.
  24. (1999). Genetic heterogeneity in familial nonmedullary thyroidcarcinoma:exclusionoflinkage to RET, MNG1, and TCO in 56 families.
  25. (2000). Germline mutations of the APC gene in patients with FAP associated thyroid carcinoma. ResultsfromaEuropeancooperative study.
  26. (2011). Immunohistochemical staining of thyroidectomy specimens for PTEN can aid in the identification of patients with Cowden syndrome.
  27. (2010). in Carney complex.
  28. (2012). In patients with thyroid cancer of follicular cell origin, a family history of nonmedullary thyroid cancer in one first-degree relative is associated with more aggressive disease.
  29. (2000). Is familialnonmedullarythyroidcarcinoma more aggressive than sporadic thyroid cancer? A multicenter series.
  30. (2001). Localization of a susceptibility gene for familial nonmedullary thyroid carcinoma to chromosome 2q21.
  31. (2006). On the prevalence of familial nonmedullary thyroid cancer in multiple affected kindreds.
  32. (2000). Papillary thyroid carcinomaassociatedwithpapillaryrenal neoplasia: genetic linkage analysis of a distinct heritable tumor syndrome.
  33. (2007). Prevalence of thyroid cancer familial adenomatous polyposis syndrome and the role of screening ultrasound examinations.
  34. (1985). The complex of myxomas, spotty pigmentation, and endocrine overactivity.
  35. (2001). The spectrum and evolution of phenotypic findings in PTEN mutation positive cases of Bannayan-Riley-Ruvalcaba syndrome.
  36. (2005). The T1799A BRAF mutation is not a germline mutation in familial nonmedullary thyroid cancer.
  37. (2000). The Werner syndrome. A modelforthestudyof humanaging.
  38. (1997). Thyroid gland abnormalitiesinpatientswiththesyndromeof spottyskinpigmentation,myxomas, endocrine overactivity, and schwannomas (Carney complex).
  39. (1999). Unusual features of thyroidcarcinomasinJapanesepatients with Werner syndrome and possible genotype-phenotype relations to cell type and race.
  40. (1989). Upper gastrointestinal cancer in patients with familial adenomatous polyposis.
  41. (2012). Volume 3 | Article 61 | 5Son and Nosé Familial follicular cell-derived thyroid carcinoma

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.